These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35973073)

  • 1. A Self-Immolative Fluorescent Probe for Selective Detection of SARS-CoV-2 Main Protease.
    Xu M; Zhou J; Cheng Y; Jin Z; Clark AE; He T; Yim W; Li Y; Chang YC; Wu Z; Fajtová P; O'Donoghue AJ; Carlin AF; Todd MD; Jokerst JV
    Anal Chem; 2022 Aug; 94(34):11728-11733. PubMed ID: 35973073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Dual-Color Fluorescent Probe Allows Simultaneous Imaging of Main and Papain-like Proteases of SARS-CoV-2-Infected Cells for Accurate Detection and Rapid Inhibitor Screening.
    Cheng Y; Borum RM; Clark AE; Jin Z; Moore C; Fajtová P; O'Donoghue AJ; Carlin AF; Jokerst JV
    Angew Chem Int Ed Engl; 2022 Feb; 61(9):e202113617. PubMed ID: 34889013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Label-free Sensing of Main Protease Activity of SARS-CoV-2 with an Aerolysin Nanopore.
    Zhou X; Tang R; Li Y; Zhang S; Xi D
    Chem Asian J; 2022 Nov; 17(21):e202200747. PubMed ID: 36029274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease-Responsive Peptide-Conjugated Mitochondrial-Targeting AIEgens for Selective Imaging and Inhibition of SARS-CoV-2-Infected Cells.
    Cheng Y; Clark AE; Zhou J; He T; Li Y; Borum RM; Creyer MN; Xu M; Jin Z; Zhou J; Yim W; Wu Z; Fajtová P; O'Donoghue AJ; Carlin AF; Jokerst JV
    ACS Nano; 2022 Aug; 16(8):12305-12317. PubMed ID: 35878004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-Based Identification of Naphthoquinones and Derivatives as Novel Inhibitors of Main Protease M
    Santos LH; Kronenberger T; Almeida RG; Silva EB; Rocha REO; Oliveira JC; Barreto LV; Skinner D; Fajtová P; Giardini MA; Woodworth B; Bardine C; Lourenço AL; Craik CS; Poso A; Podust LM; McKerrow JH; Siqueira-Neto JL; O'Donoghue AJ; da Silva Júnior EN; Ferreira RS
    J Chem Inf Model; 2022 Dec; 62(24):6553-6573. PubMed ID: 35960688
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Huang ST; Chen Y; Chang WC; Chen HF; Lai HC; Lin YC; Wang WJ; Wang YC; Yang CS; Wang SC; Hung MC
    Viruses; 2021 May; 13(5):. PubMed ID: 34063247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.
    Koudelka T; Boger J; Henkel A; Schönherr R; Krantz S; Fuchs S; Rodríguez E; Redecke L; Tholey A
    Proteomics; 2021 Jan; 21(2):e2000246. PubMed ID: 33111431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 M
    Rut W; Groborz K; Zhang L; Sun X; Zmudzinski M; Pawlik B; Wang X; Jochmans D; Neyts J; Młynarski W; Hilgenfeld R; Drag M
    Nat Chem Biol; 2021 Feb; 17(2):222-228. PubMed ID: 33093684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing an Analogue Based In Silico Pipeline in the Pursuit of Novel Inhibitory Scaffolds against the SARS Coronavirus 2 Papain-Like Protease.
    Hajbabaie R; Harper MT; Rahman T
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33672721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the Dimerization and Activity of SARS-CoV-2 Main Protease through Reversible Glutathionylation of Cysteine 300.
    Davis DA; Bulut H; Shrestha P; Yaparla A; Jaeger HK; Hattori SI; Wingfield PT; Mieyal JJ; Mitsuya H; Yarchoan R
    mBio; 2021 Aug; 12(4):e0209421. PubMed ID: 34399606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emerging SARS-CoV-2 papain-like protease: Its relationship with recent coronavirus epidemics.
    Kandeel M; Kitade Y; Fayez M; Venugopala KN; Ibrahim A
    J Med Virol; 2021 Mar; 93(3):1581-1588. PubMed ID: 32902889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput screening of SARS-CoV-2 main and papain-like protease inhibitors.
    Zang Y; Su M; Wang Q; Cheng X; Zhang W; Zhao Y; Chen T; Jiang Y; Shen Q; Du J; Tan Q; Wang P; Gao L; Jin Z; Zhang M; Li C; Zhu Y; Feng B; Tang B; Xie H; Wang MW; Zheng M; Pan X; Yang H; Xu Y; Wu B; Zhang L; Rao Z; Yang X; Jiang H; Xiao G; Zhao Q; Li J
    Protein Cell; 2023 Jan; 14(1):17-27. PubMed ID: 36726755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of small molecules with the SARS-CoV-2 papain-like protease: In silico studies and in vitro validation of protease activity inhibition using an enzymatic inhibition assay.
    Pitsillou E; Liang J; Ververis K; Hung A; Karagiannis TC
    J Mol Graph Model; 2021 May; 104():107851. PubMed ID: 33556646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting SARS-CoV-2 viral proteases as a therapeutic strategy to treat COVID-19.
    Anirudhan V; Lee H; Cheng H; Cooper L; Rong L
    J Med Virol; 2021 May; 93(5):2722-2734. PubMed ID: 33475167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass Spectrometric Assays Reveal Discrepancies in Inhibition Profiles for the SARS-CoV-2 Papain-Like Protease.
    Brewitz L; Kamps JJAG; Lukacik P; Strain-Damerell C; Zhao Y; Tumber A; Malla TR; Orville AM; Walsh MA; Schofield CJ
    ChemMedChem; 2022 May; 17(9):e202200016. PubMed ID: 35085423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorine Atoms on C
    Chaves OA; Rodrigues-Santos CE; Echevarria Á; Sacramento CQ; Fintelman-Rodrigues N; Temerozo JR; Castro-Faria-Neto HC; Souza TMLE
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges for Targeting SARS-CoV-2 Proteases as a Therapeutic Strategy for COVID-19.
    Steuten K; Kim H; Widen JC; Babin BM; Onguka O; Lovell S; Bolgi O; Cerikan B; Neufeldt CJ; Cortese M; Muir RK; Bennett JM; Geiss-Friedlander R; Peters C; Bartenschlager R; Bogyo M
    ACS Infect Dis; 2021 Jun; 7(6):1457-1468. PubMed ID: 33570381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multi-pronged evaluation of aldehyde-based tripeptidyl main protease inhibitors as SARS-CoV-2 antivirals.
    Ma Y; Yang KS; Geng ZZ; Alugubelli YR; Shaabani N; Vatansever EC; Ma XR; Cho CC; Khatua K; Xiao J; Blankenship LR; Yu G; Sankaran B; Li P; Allen R; Ji H; Xu S; Liu WR
    Eur J Med Chem; 2022 Oct; 240():114570. PubMed ID: 35779291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational Selectivity Assessment of Protease Inhibitors against SARS-CoV-2.
    Fischer A; Sellner M; Mitusińska K; Bzówka M; Lill MA; Góra A; Smieško M
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Pyridone natural products as inhibitors of SARS-CoV-2 main protease.
    Forrestall KL; Burley DE; Cash MK; Pottie IR; Darvesh S
    Chem Biol Interact; 2021 Feb; 335():109348. PubMed ID: 33278462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.